Literature DB >> 18172174

Metformin for the treatment of the polycystic ovary syndrome.

John E Nestler1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18172174     DOI: 10.1056/NEJMct0707092

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  66 in total

1.  Metformin: historical overview.

Authors:  Clifford J Bailey
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

Authors:  Kristen Farrell; Michael H Antoni
Journal:  Fertil Steril       Date:  2010-05-14       Impact factor: 7.329

Review 3.  Potential applications for biguanides in oncology.

Authors:  Michael Pollak
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

4.  Inadequacy of initiating rosuvastatin then metformin on biochemical profile of polycystic ovarian syndrome patients.

Authors:  G Ghazeeri; H A Abbas; B Skaff; S Harajly; J Awwad
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

Review 5.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

6.  Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.

Authors:  C Kim; S D Harlow; C A Karvonen-Gutierrez; J F Randolph; M Helmuth; S Kong; B Nan; R Carlos
Journal:  Diabet Med       Date:  2013-06-07       Impact factor: 4.359

7.  Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.

Authors:  Xin Li; Peng Cui; Hong-Yuan Jiang; Yan-Rong Guo; Bano Pishdari; Min Hu; Yi Feng; Håkan Billig; Ruijin Shao
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

Review 8.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

9.  Metformin and cancer: Technical and clinical implications for FDG-PET imaging.

Authors:  Selene Capitanio; Cecilia Marini; Gianmario Sambuceti; Silvia Morbelli
Journal:  World J Radiol       Date:  2015-03-28

Review 10.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.